Table 2.
Prevalence of comorbidities in patients undergoing RA‐TKA or C‐TKA.
RA‐TKA (%) | C‐TKA (%) | Significance | |
---|---|---|---|
Hypertension diagnosis | 57.6 | 59.4 | p < 0.0001 |
Dyslipidemia diagnosis | 44.1 | 46.6 | p < 0.0001 |
Sleep apnoea diagnosis | 13.8 | 13.2 | p < 0.0001 |
Chronic anaemia | 4.9 | 5.9 | p < 0.0001 |
Alcohol abuse | 0.7 | 0.9 | p < 0.0001 |
Osteoporosis | 3.7 | 4 | p < 0.0001 |
Mental disorders | 27.9 | 29 | p < 0.0001 |
Parkinson disease | 0.5 | 0.6 | p = 0.191 |
Type 2 diabetes | 19.2 | 21.6 | p < 0.0001 |
Renal disease | 5.5 | 7.1 | p < 0.0001 |
Congestive heart failure | 1.2 | 1.3 | p = 0.017 |
Chronic lung disease | 5.0 | 6.0 | p < 0.0001 |
Note: This table displays the prevalence of common comorbidities among patients who underwent either RA‐TKA or C‐TKA.
Abbreviations: C‐TKA, conventional total knee arthroplasty; RA‐TKA, robotic‐assisted total knee arthroplasty.